Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Allstate Corporation (ALL), Stryker Corporation (SYK): The Shorts Are Piling Into These Stocks. Should You Be Worried?

The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term. But when you look at individual stocks, you’ll find plenty that lose money over the long haul. According to hedge fund institution Blackstar Funds, even with dividends included, between 1983 and 2006, 64% of stocks underperformed the Russell 3000, a broad-scope market index.

Stryker Corporation (NYSE:SYK)A large influx of short-sellers shouldn’t be a condemning factor to any company, but it could be a red flag from traders that something may not be as cut-and-dried as it appears. Let’s look at three companies that have seen a rapid increase in the number of shares sold short and see whether traders are blowing smoke or if their worry has some merit.

Company Short Increase Feb. 28 to March 15 Short Shares as a % of Float
Allstate (NYSE:ALL) 151.3% 3%
Stryker (NYSE:SYK) 53.8% 2.7%
Sunoco Logistics Partners (NYSE:SXL) 61.5% 1.3%

Source: The Wall Street Journal.

In good hands
It isn’t hard to understand why short-sellers have piled into property, casualty, and life insurer The Allstate Corporation (NYSE:ALL) in recent weeks: Its share price has doubled over the past 16 months, which is no easy feat for an insurance company. It’s even more impressive if you consider that this amazing run comes after two catastrophic events in back-to-back years — the tornado outbreaks of 2011 and Hurricane Sandy of 2012. In spite of this huge run, I’m still convinced that short-sellers are barking up the wrong tree by betting against The Allstate Corporation (NYSE:ALL).

In the fourth quarter, The Allstate Corporation (NYSE:ALL) investors witnessed profits tumbling 45% as the company’s property-liability combined ratio (a measure of how profitable it is to underwrite policies) rose to 101.7% from 90.9% in the year earlier — a figure under 100% would signify profitable underwriting. This was a direct response to a spike in claims related to Sandy, but it wasn’t out of the ordinary from the figures we’ve seen with Allstate peers. P&C insurer The Chubb Corporation (NYSE:CB), for instance, really took it on the chin with a loss of nearly $900 million from Hurricane Sandy, which wiped off about $2 in EPS from its bottom line.

Even including the effects of Hurricane Sandy, property-liability net premiums rose 3.3% to $6.64 billion, which was well ahead of estimates. What this shows me is that Allstate is luring in new customers with its somewhat aggressive advertising campaign, and it’s easily able to boost premium pricing. The interesting thing about catastrophe losses is that they’re often short-lived as they give insurers a justifiable reason to boost premiums. At less than 10 times forward earnings, Allstate is not a company I’d dare consider betting against.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.